Published on 20 Apr 2024 on Simply Wall St. via Yahoo Finance
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
Key Insights
Abbott Laboratories to hold its Annual General Meeting on 26th of AprilTotal pay for CEO Robert Ford includes US$1.50m salaryTotal compensation is 68% above industry averageOver the past three years, Abbott Laboratories' EPS grew by 0.3% and over the past three years, the total loss to shareholders 8.2%
In the past three years, the share price of Abbott Laboratories (NYSE:ABT) has struggled to generate growth for its shareholders. What is concerning is that despite positive EPS growth, the share price has not tracked the trend in fundamentals. These are some of the concerns that shareholders may want to bring up at the next AGM held on 26th of April. Voting on resolutions such as executive remuneration and other matters could also be a way to influence management. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment.